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Abstract 
 
Excluding pregnancy in individuals prior to initiating contraception is important. The 
Pregnancy Reasonably Excluded Guide (PREG) uses twelve questions related to a patient’s 
reproductive history to effectively rule out pregnancy without administering a urine pregnancy 
screen, saving the patient both time and money. The PREG survey was given at Mayo Clinic in 
Rochester, MN, from 2015 to 2018 to all patients receiving an Intrauterine Device or Subdermal 
Implant.  
This study examined data from the 2018 collection year to determine if urine screening 
requests by providers were reduced from the pre-PREG data. It also determined whether urine 
tests were requested disproportionally for patients by their age range or type of contraceptive 
procedure. One-hundred sixty-eight women between the ages of 18 and 50 were included, with 
the majority identifying as white (84%) between the ages of 18 and 31 (54%). 
Using a Chi-square analysis, it was found that neither urine test by age (p=0.69) nor 
urine test by procedure (p=0.98) were significant. Urine tests were not requested more often 
for certain procedures or by patient age. However, the number of urine screens requested pre-
PREG compared to the number requested post-PREG for the year 2018 was significant (P<0.01).  
Through implementation of the PREG survey, urine pregnancy testing was drastically 
reduced and in turn, there were reduced costs to patients and the clinics.   
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Introduction 
Unplanned pregnancy is defined by the CDC as a pregnancy that is unwanted or 
mistimed (2015), and in the United States, approximately 50% of pregnancies are unplanned 
(Winner, et al., 2012). According to Gibson, Koenig, & Hindin (2008), there are a handful of ill 
effects that stem from an unplanned pregnancy for both the child and the parents. These 
include higher risk behaviors in mothers like continuing to smoke, drink alcohol, or use illegal 
drugs after a pregnancy is confirmed. In one study, women with unintended pregnancies were 
26% less likely to quit smoking, more likely to postpone prenatal care, and less likely to 
breastfeed or breastfeed for less than the recommended time (Gibson, et al., 2012). Effects to 
mothers include an increase in depression, unsafe abortion, and maternal death (Gibson, et al., 
2012).  
Some of the most effective contraceptive methods to prevent these negative outcomes 
are Long-Active Reversible Contraceptives or LARC methods. The category includes intrauterine 
devices like Mirena and Paragard, and subdermal implants like Nexplanon. While these 
methods are extremely effective, failing less than 1% of the time, only 6% of women on 
hormonal contraception were using these methods in 2012 (Winner, et al., 2012). 
There are a few possible barriers to choosing LARC methods. The first is a lack of 
comfort inserting the devices among primary care providers, who are often the main providers 
of women’s health care. One study found that 87% of respondents were not trained to place 
subdermal implants and 41% were not trained to place IUDs (Lunde, et al., 2014). Having 
providers who are trained in LARC method insertion is the strongest predictor of their patients’ 
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use of the method, as those who lack training are less likely to recommend the method. 
Greenberg, et al., 2012).  
  Once patients have decided that a LARC method is right for them, there are a few 
barriers that stand between them and the actual procedure. One is that providers should be 
“reasonably certain” that patients are not already pregnant before beginning a new 
contraceptive method, due in part to the redundancy of starting the method and the belief of 
some providers that contraceptives can cause harm to an early pregnancy (Morroni, Findley, 
Westhoff, 2017). Two accepted ways to determine pregnancy status are by administering a 
pregnancy test, or by having the patient complete the procedure during their menses. These 
requirements can prove difficult to women who have difficulty traveling to appointments, need 
time off work, or need to be on a birth control method as soon as possible. In addition, luteal 
phase pregnancies may not be detected by a urine test or indicated by a lack of active bleeding.  
A common problem, however, is that women experience delays when waiting for urine 
pregnancy test results, or may not be able to accurately take a urine pregnancy test. Morroni et 
al.  found that women were less likely to return for a second appointment and women who did 
return were 60% more likely to have gotten pregnant in the meantime (2017).  
  A method that deserves exploration is the use of a pregnancy exclusion checklist. 
Implementing a checklist would allow providers to forgo a urine screen by reasonably excluding 
pregnancy based on a survey with questions related to menstrual cycle, sexual history, and 
prior contraceptive use. Min, Buckel, Secura, Peipert, and Madden (2014) found that their six-
question exclusion guide had an accuracy of ruling out luteal pregnancy in 99% of women who 
also had a negative urine pregnancy test and ruled out typical pregnancy in 69% of women who 
 5 
had a negative pregnancy test. Another study looked at using a pregnancy exclusion checklist in 
teenagers and younger women. Whiteman, et al. looked at a group of black females ages 14-19 
and found their guide had a sensitivity range of 55%-100% and a specificity range of 39% to 89% 
(2014). The range of results could be due to the irregularity that is typical of younger women’s 
menstrual cycles. 
Mayo Clinic in Rochester, Minnesota has developed their own version of a survey titled 
“Pregnancy Reasonably Excluded Guide” or “PREG”. They implemented the 12-question patient 
survey in 2015 and, when appropriate, have been using it in place of traditional pregnancy tests 
prior to gynecological procedures. Additional urine testing could still be requested at the 
provider’s discretion after discussing the survey results with the patient and if concerns for 
pregnancy were still present. This study aimed to examine whether the PREG survey effectively 
reduced the number of urine tests performed from the pre-PREG data of 2015 to the post-PREG 
data of 2018. It also looked at whether when additional urine testing was requested, if it was 
done so more often for certain age groups or certain procedure types (intrauterine device vs 
subdermal implant).  
Methods 
The PREG survey was given to all patients when they checked in as part of their pre-
gynecology procedure appointment paperwork and health histories. (See appendix A for survey 
questions and B for the scoring guide.) Only the surveys of those who had consented to 
research at Mayo Clinic were included in the study with an original sample of 1,012 female 
patients ages eighteen to fifty. The survey answers were entered into an excel sheet, with 
additional chart review completed if necessary to clarify patients’ answers.  
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For this post-PREG study, the number of requested urine screens from the 2018 collection 
period (January through April) was compared with the pre-PREG sample from the 2015 
collection period (January through September). There were a total of 185 patients ages 
eighteen to fifty in the pre-PREG group and 168 patients ages eighteen to fifty in the post-PREG 
group. Figure A below shows the age breakdown of the 168 patients and figure B shows the 
racial representation present, both from post-PREG in 2018. Other demographic data from the 
pre-PREG group was not available for comparison. 
 
Figure A: Age distribution of patients who took PREG in 2018 
54%
29%
17%
2018 Age Distribution
18-30
31-40
41-50
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Figure B: Race distribution of patients who took PREG in 2018 
The PREG survey (Appendix A) includes twelve questions including the following: 
1.    I am pregnant. 
2.    I’ve had a bilateral tubal ligation (“tubes tied,” Essure with confirmatory testing). 
3.    I’ve had a hysterectomy and/or bilateral salpingo-oophorectomy (both ovaries removed). 
4.    I am menopausal and greater than 45 years old- no period spontaneously for the past 12 
months. 
5.    I have a current IUD (Mirena, Skyla, ParaGard, Liletta) in place. 
6.    I have a current contraceptive implant (Nexplanon, Implanon) in place. 
7.    I have not had sexual intercourse with a man since the start of my last normal period 
8.    My partner has had a vasectomy and he has had a negative post-surgery semen analysis. 
2% 4%
3%
7%
84%
2018 Race Distribution
African
Asian
Did Not Disclose
Other
White
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9.    I started bleeding from a normal period within the last seven days. 
10.    I reliably use hormonal contraception (“the pill,” Depo Provera shots, patch, ring). 
11.    I think I may be pregnant or would like a pregnancy test. 
12.    None of these apply 
To score the survey (see Appendix B for full scoring guide), the questions are divided 
into three groups: A (Questions 1-6), B (Questions 7-10), and C (Questions 11 and 12). Women 
who answered questions in Category A were deemed unlikely to be pregnant today or become 
pregnant soon. They are physically unable to become pregnant or use a contraceptive method 
that is free of human error and therefore more effective. Category B women were unlikely to 
be pregnant today but would need additional evaluation if they were to need to come back in 
the future. These women are less likely to be pregnant, but the questions rely more on the 
patient’s report and the accuracy of their recall. The questions can also not rule out a luteal 
pregnancy with question #9. Women answering from Category C could not rule out pregnancy 
today and would need some type of pregnancy testing prior to their procedure and if it was 
determined a pregnancy test would not be accurate due to recent sexual activity and menstrual 
cycle, they would be asked to rescheduled and come back when they could complete the 
pregnancy test and the results would be more accurate.  
 Data is summarized using counts and percentages.  A chi square analysis was performed 
to determine whether urine tests were requested more often pre-PREG compared to post-
PREG.   
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A Chi-square analysis was also used to determine if urine tests were requested (a) more 
often for either the subdermal implant or IUD or (b) more often for a certain age range or type 
of contraceptive procedure.  A p-value < 0.05 was considered statistically significant. 
Results 
Below, Table A shows the breakdown of answers given on the PREG survey in 2018. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A: Breakdown of 2018 PREG survey patient responses 
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Only a small percentage (0.6%) had been requested to complete a urine test prior to 
their appointment. Additional urine screens could have been requested after reviewing a 
patient’s survey. The majority (56%) chose an option in Category B, which indicated they were 
unlikely to be pregnant today, but would need additional evaluation in the future.  
Of the 185 patients from pre-PREG in 2015, 98 (53%) were requested to have urine 
screens.  Figure E shows there was a statistically significant difference in the percentage of 
urine screens ordered in 2015 compared to 2018 as shown in Figure C (53% vs. 16%. P<0.01).  
Figure C: Comparison of requested urine screens requested pre- and post- PREG survey 
 
Out of the 168 patients in 2018, the majority were white (84.52%) and between the 
ages of 18 and 30 (54.17%). The mean age was to undergo a contraceptive procedure was 30 
and most patients (55.35%) had never given birth. Demographic information for the pre-PREG 
patients was not available for comparison. See Table B below for additional demographic 
information. 
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Table B: Demographic information for patients who took PREG in 2018 
 
 
 16% of patients (21 out of 131) who received an IUD had a urine test and 16% of 
patients (6 out of 37) who received a subdermal had a urine test.  There was no association 
between type of protection and provider decision for a urine screening (p>0.05).   
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Figure D below shows a breakdown of the urine test requests by IUD insertion or subdermal 
implant 
Figure D: Breakdown of urine screens requested by procedure type 
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 A second question to be determined by the data was whether urine tests were 
requested more often for one age group compared to another. The distribution of urine tests 
completed among the three age groups (18-30, 31-40, and 41-50) were similar to each other 
(p>0.05) suggesting that a provider was no more likely to request patients of certain ages to 
complete urine tests more often than patients in other age groups.  Figure E shows a 
breakdown of the age groups and requested urine tests and illustrates a similar distribution 
among them. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure E: Breakdown of urine screens requested by age group 
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Discussion 
 The main goal of the study was to determine if adding the survey helped to reduce the 
number of urine screens requested by providers prior to procedures, indicated by few ordered 
urine screens.  Additional goals were to confirm if there were any biases towards a certain 
procedure or age range in terms of requesting a urine screen. The percentage of urine screens 
requested dropped significantly from the pre-PREG collection period (January to August 2015) 
to the post-PREG collection period. It is possible that the percentage of urine screens dropped 
more dramatically in this study because it compared only the most recent post-PREG data from 
2018 to 2015 pre-PREG data. For example, comparing pre-PREG 2015 urine screen data to post-
PREG 2016 data likely shows a more modest drop in urine screen orders as providers were still 
learning to use the survey and trust its recommendations. 
 The results of the analysis done on pre- and post- PREG survey answers support the 
continued use of the survey in the primary care gynecology clinic. It provides a convenient way 
for patients to reasonably exclude pregnancy without the extra cost of completing a urine test 
or the inconvenience of scheduling an appointment during menses. No patients in the sample 
had any complications such as device expulsion and no patients were actually pregnant when 
the PREG survey indicated it was unlikely up through the end of data collection in late 2018.  
In addition, being able to do same-day procedures opened provider accessibility 
because patients did not need to use two appointment slots on different days. Because patients 
are less likely to return for a second appointment (Morroni et al, 2017), patients should be set 
up as soon as possible with their preferred method, preferably same-day to reduce chances of 
pregnancy while waiting for a second appointment.  
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 The PREG survey has potential to be useful in areas other than gynecology and primary 
care. Pregnancy testing is also done prior to surgeries and other kinds of procedures (Kahn, et 
al., 2008) and it could be a useful tool to rule out pregnancy in those patients as well. Additional 
research would need to be done to determine if there was a difference in how providers not 
specialized in gynecology or primary care would evaluate the survey results, particularly for the 
women in Category B, who are not pregnant today but may in the future. It’s possible these 
providers would not be as confident in the survey and therefore still request urine tests. It 
would be necessary to look at whether safety for patients was affected based on who is reading 
the results.  
 Another area for additional study would be to look at the use of the PREG survey in 
younger patients. Unintended pregnancy among teenagers is a current public health issue and 
teenagers are more likely to stick with a contraceptive method that does not require extra 
thought or effort the way oral contraceptives and condoms do. (Fleming, Sokoloff, & Raine, 
2010). It would be important to look at the efficacy of the survey to exclude pregnancy and how 
issues commonly affecting teenagers like menstrual irregularity would affect the results.  
 
Limitations 
 Limitations of this study include having a small sample size to analyze. It’s also possible 
that different providers were more (or less) conservative in their decisions to use the PREG 
survey as the deciding factor for requesting urine screens. Another limitation was only using 
data from patients aged 18-50. Data from patients older than 50 and younger than 18 were 
included in the original data, but removed for this study. It is possible a bias in requesting urine 
tests could exist for older or younger patients.  
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Conclusion 
 
 LARC methods are the most effective types of birth control, removing the possibility of 
human error.  When pregnancies are unplanned, they can come with an array of negative 
effects and behaviors that can affect a child for years to come. When a woman is ready to 
initiate a contraceptive method, it’s important to be able to get it to her in a timely manner to 
further reduce her chance of unplanned pregnancy. The PREG survey has been shown to have a 
positive effect on patients by accurately and safely allowing them to have the procedures they 
need without delay.  
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